(1498877) XPO1 mutations identify early stage CLL characterized by shorter time to first treatment and enhanced BCR signaling

Primary Author; Presenting Author(s)

• 

  Riccardo Moia, MD

  Postdoctoral Fellow
  Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont
  Novara, Italy

  Slides

Co-Author(s)

• DT

  Donatella Talotta, Dr

  Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale
  Novara, Italy
• LT

  Lodovico Terzi di Bergamo, MD

  Institute of Oncology Research, Università della Svizzera Italiana
  Bellinzona, Switzerland
• RB

  Riccardo Bomben, Dr

  Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Italy
• GF

  Gabriela Forestieri, Dr

  Laboratory of Experimental Hematology, Institute of Oncology Research
  Bellinzona, Switzerland
• VS

  Valeria Spina, Dr

  Institute of Oncology Research
• AB

  Alessio Bruscaggin, Dr

  Institute of Oncology Research
• CC

  Chiara Cosentino, Dr
• MA

  Mohammad Almasri, Dr

  Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale
  Novara, Italy
• RD

  Riccardo Dondolin, Dr

  Division of Hematology, Department of Translational Medicine, Università Del Piemonte Orientale
  Novara, Italy
• TB

  Tamara Bittolo, PhD

  Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Italy
• AZ

  Antonella Zucchetto, PhD

  Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Italy
• SB

  Stefano Baldoni, Dr

  Department of Life, Hematology Section, Health and Environmental Sciences, University of L'Aquila
  Perugia, Italy
• Id

  Ilaria del Giudice, Dr

  Policlinico Umberto I, Università "La Sapienza," Istituto Ematologia, Dipartimento di Medicina Traslazionale e di Precisione
  Rome, Italy
• FM

  Francesca Romana Mauro, Dr

  Department of Translational and Precision Medicine, Hematology unit, 'Sapienza' University
  Rome, Lazio, Italy
• RM

  Rossana Maffei, Dr

  Department of Medical Sciences, Section of Hematology, University of Modena and Reggio Emilia
  Modena, Italy
• AC

  Annalisa Chiarenza, Dr

  Division of Hematology, Policlinico, Department of Surgery and Medical Specialties, University of Catania
  Catania, Italy
• AT

  Agostino Tafuri, Dr

  Azienda Ospedaliera Universitaria “Sant’Andrea” - Sapienza Università di Roma University Hospital “Sant’Andrea” - Sapienza, University of Rome
  Roma, Lazio, Italy
• RL

  Roberta Laureana, MD

  Division of Haematology, University of Tor Vergata
  Rome, Italy
• Md

  Maria Ilaria del Principe, MD

  Università degli studi di Roma Tor Vergata
  Rome, Italy
• FZ

  Francesco Zaja, Dr

  Department of Medical, Surgical and Health Sciences, University of Trieste
  Trieste, Italy
• GD

  Giovanni D'Arena, Dr

  Physician
  IRCCS Centro Di Riferimento Oncologico Della Basilicata
  Vallo della Lucania, Campania, Italy
• JO

  Jacopo Olivieri, MD

  Clinica Ematologia di Udine
  Udine, Italy
• SR

  Silvia Rasi, Dr

  University of Eastern Piedmont, Italy
• AM

  Abdurraouf Mahmoud, Dr

  Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale
  Novara, Italy
• WA

  Wael Al Essa, Dr

  ivision of Hematology, Department of Translational Medicine, Università del Piemonte Orientale
  Novara, Italy
• BA

  Bassel Awikeh, Dr

  Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale
  Novara, Italy
• SK

  Sreekar Kogila, Dr

  Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale
  Novara, Italy
• MB

  Matteo Bellia, Dr

  Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale
  Novara, Italy
• SM

  Samir Mouhssine, Mr

  Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale
  Novara, Italy
• PS

  Paolo Sportoletti, MD

  Associate Professor
  A.O. Santa Maria della Misericordia di Perugia
  Perugia, Umbria, Italy
• RM

  Roberto Marasca, Dr

  Department of Medical Sciences, Section of Hematology, University of Modena and Reggio Emilia
  Modena, Italy
• 

  Lydia Scarfò, MD

  Assistant Professor
  Vita-Salute San Raffaele University
  Milano, Italy
• 

  Paolo Ghia, MD, PhD

  Professor of Medical Oncology
  Strategic Research Program on Chronic Lymphocytic Leukemia, Division of Experimental Oncology, IRCCS Ospedale San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy
  Milan, Lombardia, Italy
• VG

  Valter Gattei, Professor

  Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Italy
• RF

  Robin Foà, Professor

  Department of Translational and Precision Medicine, Hematology unit, 'Sapienza' University
  Rome, Lazio, Italy
• 

  Davide Rossi, Professor

  Institute of Oncology Research
  Oncology Institute of Southern Switzerland IOSI
  Bellinzona, Switzerland
• 

  Gianluca Gaidano, Professor

  Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont
  Novaro, Italy